Eyecarrot Innovations: Technology to Transform Vision Healthcare

February 19, 2020

Healthcare technology focused on the vision industry

Eyecarrot Innovations is a Toronto-based healthcare technology company. They're developing a mobile-first software-centered service platform for the vision development, vision rehabilitation, and vision performance industries.

"A technology like ours can make a difference in the world and our company's position to do that.", says Founder and CEO, Adam Cegielski.

About the Binovi Platform

Eyecarrot’s BinoviTM Platform is an innovative technology solution. Further, it integrates software, hardware, data, and expert knowledge to help optometrists treat vision-related issues with in-office therapy and doctor-led home-based activities, and help trainers and athletes improve and maintain performance in sport and in life.

Vision for Sports

Much of the research in sports in the last few decades has focused on nutrition and bio-mechanics. Moreover, the work has been done largely without changes to the visual system. This leaves the potential performance improvements on the table. Further, Sports Vision Training is how Eyecarrot can help tailor that visual system. In fact, it can help those that rely on it, to improve performance in athletes across all sports, and all positions.

Eyecarrot is transforming how vision healthcare and vision performance services are performed and integrated while addressing key challenges across the board.

For more information on Eyecarrot Innovations Corp. (EYC:TSX.V, EYCCF:OTCQB) please fill out the form below.

You might also like

Healthcare
Lexaria Bioscience: Revolutionizing GLP-1 Drug Delivery with Patented Oral Platform

Lexaria Bioscience is setting new standards in drug delivery with its patented DehydraTECH™ oral technology, optimizing absorption for GLP-1 and other high-demand drugs.

Healthcare
Lexaria Bioscience: Advancing GLP-1 Drug Delivery with DehydraTECH™ Technology

Lexaria Bioscience’s DehydraTECH™ technology aims to redefine oral drug delivery, focusing on faster absorption and improved efficacy, with a promising impact on the GLP-1 pharmaceutical market.

Content Broadcast on: BNN Bloomberg, CNBC, Bloomberg, FOX Business News, BIZTV, Reuters, The Globe and Mail, YouTube and more!